Serono/Pfizer Rebif Co-Promotion Deal Will Use Neurontin Sales Force
Executive Summary
Pfizer's Neurontin sales force will co-promote Serono's multiple sclerosis drug Rebif under an agreement announced by the two companies July 11
You may also be interested in...
Serono Rebif Reps Will Add Amgen Novantrone Via License Deal For MS Drug
Amgen's Novantrone will be detailed by Serono's Rebif multiple sclerosis sales reps under a licensing agreement announced Nov. 13
Serono Rebif Reps Will Add Amgen Novantrone Via License Deal For MS Drug
Amgen's Novantrone will be detailed by Serono's Rebif multiple sclerosis sales reps under a licensing agreement announced Nov. 13
Serono/Pfizer Rebif Will Reach 30% Share By 2006, Serono Says
Serono is increasing its market share projection for the multiple sclerosis agent Rebif by at least five percentage points in light of its co-promotion agreement with Pfizer